1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
1 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 0.00 | - |
| Gross profit | −7.28k | 31,71% |
| Net profit | −844.33k | 80,32% |
| EBITDA | −834.97k | 79,52% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | 1.55m€ |
Number of shares | 1.81m |
52-week high/low | 3,90€ - 0,11€ |
| Dividends | No |
Beta | 1,07 |
P/E ratio | 0,34 |
PEG ratio | 0,00 |
P/B ratio | 1,05 |
P/S ratio | 0,00 |
Company profile
| Name | Protagenic Therapeutics Inc |
| CEO | Garo H. Armen |
| Employees | 2 |
Discover assets
Shareholders of Protagenic Therapeutics Inc also invest in the following assets
